BIOXINESS PHARMACEUTICALS INC has a total of 13 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CURACYTE AG, CORTECH INC and BIO MEGA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology | |
#5 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Bassiri Mansour | 12 |
#2 | Gless Richard D | 6 |
#3 | Rahimi-Larijani Afsaneh | 6 |
#4 | Swiss Gerald F | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019169029A1 | Target specific chemotherapeutic agents | |
WO2019169017A1 | Chemotherapeutic agents | |
WO2019169011A1 | Chemotherapeutic oligopeptide mimetics | |
US2018340008A1 | Antibiotic oligopeptide mimetics | |
US2018298053A1 | Antibiotic oligopeptides | |
US2018282271A1 | Antibiotic amino acid mimetics | |
EP2326619A2 | Methionine analogs and methods of using same |